Page last updated: 2024-08-16

rivastigmine and Psychomotor Agitation

rivastigmine has been researched along with Psychomotor Agitation in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's8 (80.00)29.6817
2010's2 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Choi, SH; Han, HJ; Kim, EJ; Lee, JH; Na, DL; Na, HR; Park, KW; Shim, YS; Yoon, SJ1
Osborn, GG; Saunders, AV1
Alagiakrishnan, K; Robertson, D; Sclater, A1
Kaufer, DI1
Ballard, C; Bannister, C; Douglas, S; Elvish, R; Everratt, A; Jacoby, R; Juszczak, E; Lee, L; Maddison, C; Margallo-Lana, M; O'Brien, J; Sadler, S; Swann, A; Thomas, A1
Ownby, RL1
Clare, C; Dean, C; El-Okl, M; Hensford, C; Holmes, C; Moghul, S; Wilkinson, D1
Baik, J; Han, IW; Koo, MS; Kwak, YT1
Caffarra, P; Godani, M; Majer, S; Paolello, P1
Byrne, EJ; Collins, CC; Maclean, LE1

Reviews

1 review(s) available for rivastigmine and Psychomotor Agitation

ArticleYear
Current treatments for patients with Alzheimer disease.
    The Journal of the American Osteopathic Association, 2010, Volume: 110, Issue:9 Suppl 8

    Topics: Aggression; Alzheimer Disease; Behavior Therapy; Cholinesterase Inhibitors; Depression; Excitatory Amino Acid Antagonists; Galantamine; Health Status; Humans; Memantine; Neuroprotective Agents; Parasympathomimetics; Phenylcarbamates; Psychomotor Agitation; Psychotherapy; Psychotic Disorders; Rivastigmine; Time Factors; United States; United States Food and Drug Administration

2010

Trials

4 trial(s) available for rivastigmine and Psychomotor Agitation

ArticleYear
Effects on agitation with rivastigmine patch monotherapy and combination therapy with memantine in mild to moderate Alzheimer's disease: a multicenter 24-week prospective randomized open-label study (the Korean EXelon Patch and combination with mEmantine
    Geriatrics & gerontology international, 2017, Volume: 17, Issue:3

    Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Alzheimer Disease; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Factor Analysis, Statistical; Female; Follow-Up Studies; Humans; Male; Memantine; Multivariate Analysis; Prospective Studies; Psychomotor Agitation; Republic of Korea; Risk Assessment; Rivastigmine; Severity of Illness Index; Time Factors; Treatment Outcome

2017
Quetiapine and rivastigmine and cognitive decline in Alzheimer's disease: randomised double blind placebo controlled trial.
    BMJ (Clinical research ed.), 2005, Apr-16, Volume: 330, Issue:7496

    Topics: Aged; Alzheimer Disease; Antipsychotic Agents; Cholinesterase Inhibitors; Cognition Disorders; Dibenzothiazepines; Double-Blind Method; Humans; Middle Aged; Phenylcarbamates; Psychomotor Agitation; Quetiapine Fumarate; Rivastigmine; Treatment Failure

2005
Quetiapine and rivastigmine for agitation in Alzheimer's disease.
    Current psychiatry reports, 2006, Volume: 8, Issue:1

    Topics: Alzheimer Disease; Cholinesterase Inhibitors; Cognition Disorders; Dibenzothiazepines; Disease Progression; Double-Blind Method; Humans; Phenylcarbamates; Psychomotor Agitation; Quetiapine Fumarate; Rivastigmine

2006
Risperidone and rivastigmine and agitated behaviour in severe Alzheimer's disease: a randomised double blind placebo controlled study.
    International journal of geriatric psychiatry, 2007, Volume: 22, Issue:4

    Topics: Aged, 80 and over; Alzheimer Disease; Antipsychotic Agents; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Phenylcarbamates; Psychomotor Agitation; Risperidone; Rivastigmine

2007

Other Studies

5 other study(ies) available for rivastigmine and Psychomotor Agitation

ArticleYear
Role of cholinesterase inhibitor in the management of sexual aggression in an elderly demented woman.
    Journal of the American Geriatrics Society, 2003, Volume: 51, Issue:9

    Topics: Aged; Aggression; Alzheimer Disease; Carbamates; Cholinesterase Inhibitors; Dementia, Vascular; Female; Geriatric Assessment; Humans; Neuroprotective Agents; Phenylcarbamates; Psychomotor Agitation; Rivastigmine; Sexual Behavior; Time Factors

2003
A case study in the treatment of dementia with Lewy bodies.
    Acta psychiatrica Scandinavica, 2004, Volume: 110, Issue:1

    Topics: Aged; Aged, 80 and over; Carbamates; Cognition Disorders; Donepezil; Drug Resistance; Female; Galantamine; Hallucinations; Humans; Indans; Lewy Body Disease; Neuroprotective Agents; Nootropic Agents; Phenylcarbamates; Piperidines; Psychomotor Agitation; Rivastigmine; Social Behavior

2004
Relation between cholinesterase inhibitor and Pisa syndrome.
    Lancet (London, England), 2000, Jun-24, Volume: 355, Issue:9222

    Topics: Aged; Alzheimer Disease; Carbamates; Cholinesterase Inhibitors; Donepezil; Dopamine Antagonists; Dystonia; Female; Humans; Indans; Memory Disorders; Middle Aged; Neuroprotective Agents; Nootropic Agents; Phenylcarbamates; Piperidines; Posture; Psychomotor Agitation; Risperidone; Rivastigmine; Syndrome

2000
Rivastagmine-induced agitation following transient recollection of autobiographical memory.
    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2001, Volume: 22, Issue:3

    Topics: Aged; Alzheimer Disease; Carbamates; Cholinesterase Inhibitors; Female; Humans; Phenylcarbamates; Psychomotor Agitation; Rivastigmine

2001
Dementia with Lewy bodies treated with rivastigmine: effects on cognition, neuropsychiatric symptoms, and sleep.
    International psychogeriatrics, 2001, Volume: 13, Issue:3

    Topics: Aged; Aged, 80 and over; Carbamates; Cholinesterase Inhibitors; Cognition; Female; Humans; Lewy Body Disease; Male; Middle Aged; Phenylcarbamates; Psychomotor Agitation; Rivastigmine; Sleep; Treatment Outcome

2001